Tony Hyman presents the case that most innovative research is done by young scientists early in their careers. In the USA, however, NIH funding for scientists under the age of 36 has dropped significantly for the last several decades. Hyman argues that expanding grants that are available only to young scientists and provide 5-10 years of funding would greatly encourage innovation in biomedical research.
|Download: High ResLow Res|
|Trouble Viewing? Try it on iTunes.Report a problem.|
|Share your thoughts about this video at the bottom of the page.|
About the Speaker
Tony Hyman received his BSc in Zoology from University College, London and his PhD from the Laboratory of Molecular Biology in Cambridge. He then moved to the University of California, San Francisco to pursue postdoctoral research. Hyman returned to Europe in 1993 when he joined the EMBL in Heidelberg as a young faculty member. After 6 years at the EMBL, he became a Director of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. Hyman’s lab has studied the spatial organization of the cytoplasm for many years (see Hyman’s iBioSeminar). His lab is currently focused on understanding how cells form non-membrane bound compartments.
Learn more about Dr. Hyman’s research here
- ERC Report: Qualitative Evaluation of Completed Projects Funded by the European Research Council
- ERC Press Release: New Report Reveals Impact of ERC Research
- Nature Editorial: Agencies must show that basic research is worth the investment.
- Ron Daniels iBioMagazine: Creating Opportunities for Young Investigators
- Michael Teitelbaum iBioMagazine: The Booms and Busts of Science Funding and the Case for Stabilization
- Jeremy Nathans iBioMagazine: Creativity in Science
- Keith Yamamoto iBioMagazine: Taking Risks
- Enrique De La Cruz iBioMagazine: How to Succeed in Science
- Tony Hyman’s iBioSeminar: Organization of Cytoplasm